Home » Topics » BioWorld

BioWorld
RSS

Roberts Shareholders OK Yamanouchi Buy-In

March 18, 1992

INTERVENTION WITH IMRE COLUMN SUCCEEDS

March 18, 1992

GENSIA ADOPTS POISON PILL

March 18, 1992

BIOMIRA GETS RIGHTS TO CANCER PEPTIDE

March 18, 1992

TEVA EXPANDS PHARMACHEMICAL CAPACITY

March 18, 1992

CELLULAR TRANSPLANT COMPANY FILES IPO

March 18, 1992

DATA FAVORS ALZA ORAL DELIVERY SYSTEM

March 18, 1992

ELAN TO DEBUT WRIST-BORNE DRUG DELIVERY

March 18, 1992

COMPANY DEFECTS TO NEW AMEX MARKET

March 18, 1992

SYNTHETIC TAXOL 'EXCITINGLY CLOSE'

March 18, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...